Early cancer detection powered by blood tests and AI
Huna’s AI platform unlocks the potential of routine blood tests to identify early cancer
risks, offering healthcare providers a low-cost, scalable, and non-invasive alternative to
traditional diagnostics first in Brazil and later in Latin America.
About
Huna is an AI-powered software platform revolutionizing early cancer detection by analyzing routine blood test data to assess patients’ risk of cancer before symptoms appear. Designed for healthcare providers, laboratories, Hospital, Pharmaceuticals, insurers, and governments, Huna’s system classifies cancer risk in real-time across five types: starting with breast cancer and expanding to cervical, lung, colorectal, and prostate.
The platform, already in use by many of its thrusted medical allies in Brazil, can operate independently or integrate via API. Its non-invasive approach allows mass screening at a fraction of the cost of traditional methods, helping providers diagnose earlier and reduce mortality. With >1MM data points analyzed and strong, long-term partnerships with leading Brazilian institutions, Huna is setting a new standard in preventive healthcare across the region.
>1MM
Data points analyzed
40%
Reduction in mortality from early diagnosis
Addressed Problem
In Latin America, 80% of cancer cases are detected at advanced stages due to lack of access to early screenings. Mammography and traditional tools remain costly and inaccessible for most women. Huna leverages ubiquitous blood tests and machine learning to provide a cost-effective, scalable solution—triaging high-risk patients for early intervention.
Founders
Location
- Brazil
Services
- Health Tech
- AI-Based Diagnostics
- SaaS for Cancer Detection